Exact Sciences Highlights Cologuard’s® Positive Launch Trajectory in Second Quarter 2015

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. GOOGL
10. S

Go back to Exact Sciences Highlights Cologuard’s® Positive Launch Trajectory in Second Quarter 2015

Exact Sciences (EXAS) Tops Q2 EPS by 1c

July 20, 2015 8:00 AM EDT

Exact Sciences (NASDAQ: EXAS) reported Q2 EPS of ($0.44), $0.01 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $8.1 million versus the consensus estimate of $7.96 million.

The company announced its business and financial results for the second quarter of 2015, and showed continued strong performance with more than 21,000 completed Cologuard tests for the quarter, up more than 90 percent from the first quarter, which resulted in $8.1 million in revenue. Additionally, the cumulative number of ordering physicians grew to... More